STOCK TITAN

Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Apollo Endosurgery, a leader in less invasive medical devices, will participate in Lake Street's 5th Annual Best Ideas Growth Conference on September 14-15, 2021. This virtual event will feature management teams from over 100 small-cap public companies engaging with 300 institutional investors. Apollo offers innovative therapies for gastrointestinal issues and obesity, marketed in over 75 countries. Investors can reach out to Lake Street representatives or Apollo's investor relations for attendance and meeting arrangements.

Positive
  • None.
Negative
  • None.

AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate in Lake Street's 5th Annual Best Ideas Growth Conference.

September 14-15, 2021

Lake Street's 5th Annual Best Ideas Growth Conference

Management teams from over 100 dynamic small-cap publicly traded companies will interact with over 300 institutional investors in a one-on-one conference format.

Investors interested in attending the virtual presentation or arranging meetings should contact their respective Lake Street representative or Apollo's investor relations, Matt Kreps and Jason Loeb of Darrow Associates, mkreps@darrowir.com, jloeb@darrowir.com.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal complications to the treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Apollo's common stock is traded on the Nasdaq Global Market under the symbol "APEN". For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.

Contacts:
Apollo Endosurgery, Inc.
Jeff Black, 512-279-5100
investor-relations@apolloendo.com

Darrow Associates Investor Relations
Matt Kreps, 214-597-8200
mkreps@darrowir.com
Jason Loeb, 917-579-3394
jloeb@darrowir.com

SOURCE: Apollo Endosurgery, Inc.



View source version on accesswire.com:
https://www.accesswire.com/663626/Apollo-Endosurgery-to-Present-at-Lake-Streets-5th-Annual-Best-Ideas-Growth-Conference

FAQ

When is Apollo Endosurgery participating in Lake Street's conference?

Apollo Endosurgery will participate in Lake Street's 5th Annual Best Ideas Growth Conference on September 14-15, 2021.

What is the focus of Apollo Endosurgery?

Apollo Endosurgery focuses on less invasive therapies for various gastrointestinal and bariatric conditions.

How many companies are participating in the Lake Street conference?

Over 100 small-cap publicly traded companies will participate in Lake Street's 5th Annual Best Ideas Growth Conference.

How can investors attend Apollo's presentation at the conference?

Investors interested in attending Apollo's presentation should contact their Lake Street representative or Apollo's investor relations.

What products does Apollo Endosurgery offer?

Apollo offers products like the OverStitch™ Endoscopic Suturing System and the ORBERA® Intragastric Balloon, used for less invasive medical treatments.

APEN

NASDAQ:APEN

APEN Rankings

APEN Latest News

APEN Stock Data

579.72M
55.25M
4.29%
63.41%
0.97%
Medical Devices
Healthcare
Link
United States
Austin